The Massachusetts Institute of Technology recently revealed that mouse studies of “smart insulin” showed promise. The smart insulin would activate only when needed. And folks, understandably, are excited about the prospects of managing diabetes with just a single shot.
InsulinNation has an interview with the MIT researchers, and the timing of human trials could be a long way off.
Dr. Matthew Webber, a co-author for the study, said:
“These things are very difficult, I think. It could be anywhere from a few years to a few decades or never.”
Yes … he said “never.”